Microbiology: A Human Perspective. 6th Edition. ISBN 0072995432, 978-0072995435
Microbiology: A Human Perspective. 6th Edition. ISBN 0072995432, 978-0072995435
Microbiology: A Human Perspective. 6th Edition. ISBN 0072995432, 978-0072995435
Visit the link below to download the full version of this book:
https://cheaptodownload.com/product/microbiology-a-human-perspective-6th-edition
-full-pdf-download/
nes95432_fm_i-xxxviii.indd ii 8/27/08 1:39:27 PM
sixth edition
A HUMAN PERSPECTIVE
Eugene W. Nester
University of Washington
Denise G. Anderson
University of Washington
Martha T. Nester
Published by McGraw-Hill, a business unit of The McGraw-Hill Companies, Inc., 1221 Avenue of the Americas,
New York, NY 10020. Copyright © 2009 by The McGraw-Hill Companies, Inc. All rights reserved. Previous
editions © 2007, 2004, 2001, 1998, and 1995. No part of this publication may be reproduced or distributed in
any form or by any means, or stored in a database or retrieval system, without the prior written consent of The
McGraw-Hill Companies, Inc., including, but not limited to, in any network or other electronic storage or trans-
mission, or broadcast for distance learning.
Some ancillaries, including electronic and print components, may not be available to customers outside the
United States.
This book is printed on recycled, acid-free paper containing 10% postconsumer waste.
1 2 3 4 5 6 7 8 9 0 QPD/QPD 0 9 8
ISBN 978–0–07–299543–5
MHID 0–07–299543–2
The credits section for this book begins on page C-1 and is considered an extension of the copyright page.
Microbiology : a human perspective / Eugene W. Nester ... [et al.]. — 6th ed.
p. cm.
Includes index.
ISBN 978–0–07–299543–5 — ISBN 0–07–299543–2 (hard copy : alk. paper) 1. Microbiology.
I. Nester, Eugene W.
[DNLM: 1. Microbiological Techniques. 2. Communicable Diseases—microbiology. QW 4 M62555 2009]
QR41.2.M485 2009
616.9’041—dc22 2008019596
www.mhhe.com
to our families
whose patience and endurance
made completion of this project a reality,
to our colleagues
for continuing encouragement
and advice.
PART II PART V
THE MICROBIAL WORLD APPLIED MICROBIOLOGY
vi
SUMMARY 16 SUMMARY 37
REVIEW QUESTIONS 17 REVIEW QUESTIONS 38
vii
4.5 Environmental Factors That Influence Microbial 5.4 Using Other Physical Methods to Remove or Destroy
Growth 90 Microbes 115
Temperature Requirements 90 Filtration 115
Oxygen (O2) Requirements 91 Radiation 115
pH 92 High Pressure 116
Water Availability 93
5.5 Using Chemicals to Destroy Microorganisms and
4.6 Nutritional Factors That Influence Microbial Viruses 116
Growth 93 Potency of Germicidal Chemical Formulations 117
Required Elements 93 Selecting the Appropriate Germicidal Chemical 117
Growth Factors 94 Classes of Germicidal Chemicals 118
Energy Sources 94
5.6 Preservation of Perishable Products 121
Nutritional Diversity 95
Chemical Preservatives 122
4.7 Cultivating Prokaryotes in the Laboratory 95 Low-Temperature Storage 122
General Categories of Culture Media 95 Reducing the Available Water 122
Special Types of Culture Media 96
PERSPECTIVE 5.1: Contamination of an Operating Room by a Bacterial
Providing Appropriate Atmospheric Pathogen 121
Conditions 97
FUTURE CHALLENGES: Too Much of a Good Thing? 123
Enrichment Cultures 98
SUMMARY 123
4.8 Methods to Detect and Measure Bacterial
REVIEW QUESTIONS 124
Growth 99
Direct Cell Counts 99
Viable Cell Counts 100 CHAPTER SIX
Measuring Biomass 102
Detecting Cell Products 103 Metabolism: Fueling Cell Growth 126
PERSPECTIVE 4.1: Can Prokaryotes Live on Only Rocks and A Glimpse of History 126
Water? 94 Key Terms 127
FUTURE CHALLENGES: Seeing How the Other 99% Lives 104
6.1 Principles of Metabolism 127
SUMMARY 104 Harvesting Energy 128
REVIEW QUESTIONS 105 Components of Metabolic Pathways 129
Precursor Metabolites 131
Overview of Metabolism 132
CHAPTER FIVE
6.2 Enzymes 134
Control of Microbial Growth 107 Mechanisms and Consequences of Enzyme
A Glimpse of History 107 Action 134
Cofactors and Coenzymes 135
Key Terms 108
Environmental Factors That Influence Enzyme
5.1 Approaches to Control 107 Activity 136
Principles of Control 108 Allosteric Regulation 137
Situational Considerations 108 Enzyme Inhibition 137
5.2 Selection of an Antimicrobial Procedure 110 6.3 The Central Metabolic Pathways 138
Type of Microorganism 110 Glycolysis 139
Numbers of Microorganisms Initially Pentose Phosphate Pathway 139
Present 110 Transition Step 141
Environmental Conditions 111 Tricarboxylic Acid (TCA) Cycle 142
Potential Risk of Infection 111
6.4 Respiration 142
Composition of the Item 111
The Electron Transport Chain—Generating Proton
5.3 Using Heat to Destroy Microorganisms and Motive Force 143
Viruses 111 ATP Synthase—Harvesting the Proton Motive Force to
Moist Heat 112 Synthesize ATP 145
Dry Heat 114 ATP Yield of Aerobic Respiration in Prokaryotes 146
7.4 Differences Between Eukaryotic and Prokaryotic Gene GENE TRANSFER AS A MECHANISM
Expression 175 OF GENETIC CHANGE
7.5 Regulation of Bacterial Gene Expression 176
8.6 DNA-Mediated Transformation 199
Principles of Regulation 176
Natural Competence 200
Mechanisms to Control Transcription 176
Artificial Competence 201
The lac Operon As a Model for Control of Metabolic
Pathways 177 8.7 Transduction 201
FUTURE CHALLENGES: Astrobiology: The Search for Life on Other 13.1 General Characteristics of Viruses 302
Planets 276 Virus Architecture 303
18.2 Type II Hypersensitivities: Cytotoxic 418 19.4 Observing Antigen-Antibody Aggregations 441
Transfusion Reactions 418 Precipitation Reactions 441
Hemolytic Disease of the Newborn 418 Agglutination Reactions 443
18.3 Type III Hypersensitivities: Immune 19.5 Using Labeled Antibodies to Detect Antigen-Antibody
Complex—Mediated 420 Interactions 444
Fluorescent Antibody (FA) Tests 444
18.4 Type IV Hypersensitivities: Delayed Enzyme-Linked Immunosorbent Assay (ELISA) 445
Cell–Mediated 421 Western Blotting 446
Tuberculin Skin Test 421 Fluorescence-Activated Cell Sorter (FACS) 447
Delayed Hypersensitivity in Infectious Diseases 422
Contact Hypersensitivities 422 PERSPECTIVE 19.1: Monoclonal Antibodies 440
FUTURE CHALLENGES: Global Immunization 447
18.5 Rejection of Transplanted Tissues 423
SUMMARY 447
18.6 Autoimmune Diseases 424
REVIEW QUESTIONS 448
The Spectrum of Autoimmune Reactions 425
Treatment of Autoimmune Diseases 425
CHAPTER TWENTY
18.7 Immunodeficiency Disorders 426
Primary Immunodeficiencies 426 Epidemiology 450
Secondary Immunodeficiencies 427
A Glimpse of History 450
FUTURE CHALLENGES: New Approaches to Correcting Immunologic 20.1 Principles of Epidemiology 451
Disorders 428
Rate of Disease in a Population 451
SUMMARY 428 Reservoirs of Infection 453
REVIEW QUESTIONS 429 Portals of Exit 454
SUMMARY 528
REVIEW QUESTIONS 529
24.3 Diseases Due to Anaerobic Bacterial Wound LOWER DIGESTIVE SYSTEM INFECTIONS
Infections 566
“Lockjaw“ (Tetanus) 566 25.5 Bacterial Diseases of the Lower Digestive
Gas Gangrene (Clostridial Myonecrosis) 568 System 595
“Lumpy Jaw“ (Actinomycosis) 570 Cholera 596
Shigellosis 598
24.4 Bacterial Bite Wound Infections 572 Escherichia coli Gastroenteritis 599
Pasteurella multocida Bite Wound Infections 572 Salmonellosis 601
Cat Scratch Disease 572 Campylobacteriosis 602
Streptobacillary Rat Bite Fever 574
Human Bites 574 25.6 Viral Diseases of the Lower Digestive System 604
Rotaviral Gastroenteritis 604
24.5 Fungal Wound Infections 576 Norovirus Gastroenteritis 604
“Rose Gardener’s Disease“ (Sporotrichosis) 576 Hepatitis A 605
Hepatitis B 606
CASE PRESENTATION 573
Hepatitis C 608
PERSPECTIVE 24.1: Infection Caused by a Human “Bite“ 575
FUTURE CHALLENGES: Staying Ahead in the Race with 25.7 Protozoan Diseases of the Lower Digestive
Staphylococcus aureus 578 System 609
SUMMARY 578 Giardiasis 609
REVIEW QUESTIONS 579 Cryptosporidiosis 610
Cyclosporiasis 612
Amebiasis 612
CHAPTER TWENTY FIVE CASE PRESENTATION 591
Digestive System Infections 581 PERSPECTIVE 25.1: Ecology of Cholera 597
FUTURE CHALLENGES: Defeating Diarrhea 614
A Glimpse of History 581
Key Terms 582
SUMMARY 614
REVIEW QUESTIONS 616
25.1 Anatomy and Physiology 582
The Mouth 582 CHAPTER TWENTY SIX
Salivary Glands 582
The Esophagus 583 Genitourinary Infections 618
The Stomach 584
A Glimpse of History 618
The Small Intestine 584
Key Terms 619
The Pancreas 584
The Liver 584 26.1 Anatomy and Physiology 619
The Large Intestine 585 The Urinary System 619
The Genital System 620
25.2 Normal Microbiota 585
The Mouth 585 26.2 Normal Microbiota of the Genitourinary System 620
The Intestines 585
26.3 Urinary System Infections 621
Bacterial Cystitis 621
UPPER DIGESTIVE SYSTEM INFECTIONS
Leptospirosis 622
25.3 Bacterial Diseases of the Upper Digestive System 586
26.4 Genital System Diseases 625
Tooth Decay (Dental Caries) 586
Bacterial Vaginosis 625
Periodontal Disease 588
Vulvovaginal Candidiasis 625
Trench Mouth 588
Staphylococcal Toxic Shock Syndrome 626
Helicobacter pylori Gastritis 589
26.5 Sexually Transmitted Diseases: Scope of the
25.4 Viral Diseases of the Upper Digestive
Problem 628
System 592
Herpes Simplex (Cold Sores or Fever Blisters) 592 26.6 Bacterial STDs 629
Mumps 593 Gonorrhea 629
Nervous System Infections 647 28.4 Viral Diseases of the Lymphoid and Blood Vascular
Systems 686
A Glimpse of History 647 “Kissing Disease” (Infectious Mononucleosis,
Key Terms 648 “Mono”) 686
Yellow Fever 688
27.1 Anatomy and Physiology 648
Pathways to the Central Nervous System 649 28.5 Protozoan Diseases 690
Malaria 691
27.2 Bacterial Nervous System Infections 650
Meningococcal Meningitis 650 CASE PRESENTATION 688
Listeriosis 653 PERSPECTIVE 28.1: Arteriosclerosis: The Infection Hypothesis 676
Hansen’s Disease (Leprosy) 655 PERSPECTIVE 28.2: Walter Reed and Yellow Fever 690
Botulism 657 FUTURE CHALLENGES: Rethinking Malaria Control 694
27.3 Viral Diseases of the Nervous System 658 SUMMARY 694
Viral Meningitis 659 REVIEW QUESTIONS 695
Viral Encephalitis 659
Infantile Paralysis, Polio (Poliomyelitis) 661 CHAPTER TWENTY NINE
Rabies 663
HIV Disease and Complications
27.4 Fungal Diseases of the Nervous System 666
of Immunodeficiency 697
Cryptococcal Meningoencephalitis 666
A Glimpse of History 697
27.5 Protozoan Diseases of the Nervous System 667
African Sleeping Sickness 667 Key Terms 698
27.6 Transmissible Spongiform Encephalopathies 669 29.1 Human Immunodeficiency Virus (HIV) Infection and
Transmissible Spongiform Encephalopathy in AIDS 698
Humans 669 HIV Disease 699
HIV Vaccine Prospects 709
CASE PRESENTATION 651
29.2 Malignant Tumors That Complicate Acquired
PERSPECTIVE 27.1: A Rabies Survivor! 665
Immunodeficiencies 710
FUTURE CHALLENGES: Eradicate Polio: Then What? 670
Kaposi’s Sarcoma 710
SUMMARY 671 B-Lymphocytic Tumors of the Brain 711
REVIEW QUESTIONS 672 Cervical and Anal Carcinoma 711
SUMMARY 766
REVIEW QUESTIONS 767
xxii